Browsing by Author Yim, RLH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 14 of 14
TitleAuthor(s)Issue DateViews
 
A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: insights and future directions for regenerative therapeutics
Journal:Stem Cells and Development
Yim, RLHLee, TYBow, HYCMeij, BLeung, VYLCheung, KMCVavken, PSamartzis, D
2014
94
 
DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin’s Lymphomas
Journal:Frontiers in non-coding RNA
Yim, RLHKwong, YLWong, KYChim, JCS
2012
51
 
Epigenetic inactivation of the MIR129-2 in hematological malignancies
Journal:J Hematol Oncol
Wong, KYYim, RLHKwong, YLLeung, CYHui, PKCheung, FLiang, RHSJin, DYChim, JCS
2013
66
 
Epigenetic inactivation of the MIR34B/C in multiple myeloma
Journal:Blood
Wong, KYYim, RLHSo, CCJin, DYLiang, RChim, CS
2011
159
 
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study
Journal:Cancer
Singh, GHHYim, RLHLee, HKKMak, VLin, SYKho, BYip, SFLau, JSMLi, WIp, HWHwang, YYGChan, SYTTse, EWCAu, WYKumana, CRKwong, YL
2018
141
 
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis
Journal:Annals of Hematology
Singh, GHHIp, HWYim, RLHTang, WFPang, HMHLee, PLeung, GMKLi, JWYTang, KSo, JCCLeung, RYYLi, JPanagiotou, ILam, CCKKwong, YL
2019
92
 
Next-Generation Sequencing with a 54-Gene Panel Identifies Unique Mutational Profile and Prognostic Markers in Chinese Patients with Myelofibrosis
Proceeding/Conference:Blood
Singh, GHHIp, HWYim, RLHTang, TWFPang, HMHLee, PLeung, GMKLi, JWYTang, KSo, JCCLeung, RYYLi, JPanagiotou, ILam, CCKKwong, YL
2017
139
 
Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study
Journal:Cancer
Singh, GHHKumana, CRYim, RLHHwang, YYGChan, SYTYip, SFLee, HKKMak, VLau, JSMChan, CCKho, BWong, RSMLi, WLin, SYLau, CKIp, HWLeung, RYYLam, CCKKwong, YL
2019
62
 
Oral arsenic trioxide, ATRA and ascorbic acid (AAA) maintenance following first complete remission in acute promyelocytic leukaemia – Long-term results and unique prognostic indicators
Journal:Cancer
Singh, GHHYim, RLHTse, EWCKwong, YL
2020
42
 
Oral Arsenic Trioxide, ATRA and Ascorbic Acid (AAA) Maintenance Following First Complete Remission in Acute Promyelocytic Leukemia - Long-Term Data and Unique Prognostic Indicators
Proceeding/Conference:Blood
Singh, GHHYim, RLHKumana, CRKwong, YL
2019
139
 
Single-Nucleotide Variations, Insertions/Deletions and Copy Number Variations in Myelodysplastic Syndrome during Disease Progression Revealed by a Single-Cell DNA Sequencing Platform
Journal:International Journal of Molecular Sciences
LEE, PYim, RLHFung, SHMiu, KKWang, ZWu, KCEAu, SSLeung, GMKLee, VHFSingh, GHH
2022
1
 
The safety and efficacy of mesenchymal stem cells for prevention or regeneration of intervertebral disc degeneration: a systematic review
Proceeding/Conference:Global Spine Congress, GSC 2013
Yim, RLHLee, JTYLeung, VYLCheung, KMCVavken, PSamartzis, D
2013
22
 
The safety and efficacy of mesenchymal stem cells for prevention or regeneration of intervertebral disc degeneration: a systematic review
Proceeding/Conference:Annual Meeting of the International Society for the Study of Lumbar Spine, ISSLS 2013
Yim, RLHLee, JTYVavken, PSamartzis, D
2013
32
 
Whole exome sequencing identifies novel mutations in relapsed or refractory acute promyelocytic leukaemia failing treatment with oral arsenic trioxide
Proceeding/Conference:Congress of the European Hematology Association, EHA 2016
Singh, GHHIp, HWLi, JYim, RLHPanagiotou, GLeung, AYHKwong, YL
2016
120
Showing results 1 to 14 of 14